Related Experiment Video

Updated: May 1, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

928

COVID-19 in pediatrics in Latin America: six years later

María L Ávila-Agüero1,2, Helena Brenes-Chacón1, Luiza Helena Falleiros-Arlant3

  • 1Pediatric Infectious Diseases Department, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera", Caja Costarricense del Seguro Social (CCSS), San José, Costa Rica.

Expert Review of Vaccines
|April 30, 2026
PubMed

Insights

The COVID-19 pandemic profoundly impacted Latin American children, especially infants, exacerbating inequities. Addressing challenges requires strengthening vaccination, education, and health systems for equitable recovery.

Area of Science:

  • Pediatric Public Health
  • Epidemiology
  • Global Health

Background:

  • The COVID-19 pandemic has had a lasting and profound impact on children in Latin America.
  • Infants, initially considered less susceptible, are among the most affected pediatric populations.
  • The pandemic has exposed and magnified existing inequities and vulnerabilities in the region.

Purpose of the Study:

  • To provide an expert perspective from SLIPE on the epidemiological situation of COVID-19 in children in Latin America.
  • To analyze the multifaceted effects of the pandemic on children's health, wellbeing, education, and immunization.
  • To offer insights into strategies for recovery and safeguarding the future of children in the region.

Main Methods:

  • This paper presents a review and expert analysis of the current epidemiological situation.
  • It synthesizes information on the pandemic's impact across various domains of child wellbeing.
  • The analysis draws upon the perspective of SLIPE, offering expert insight.

Main Results:

  • COVID-19 vaccination coverage in children is suboptimal, particularly for high-risk groups.
  • Disruptions to routine immunization programs have resulted in outbreaks of vaccine-preventable diseases.
  • The pandemic has exacerbated inequities and vulnerabilities, affecting children's health, education, and overall wellbeing.

Conclusions:

  • Strengthening COVID-19 vaccination for high-risk children and routine immunization programs is crucial.
  • Effective communication to combat misinformation and prioritizing educational recovery are essential.
  • Public policy must center on children, close equity gaps, and build resilient health systems for recovery.
Abstract

Keywords:
COVID-19Latin Americachildreneducationequitypandemicpublic healthvaccination

More Related Videos

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.0K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K